Abstract The ubiquitously expressed calpains-1 and -2 belong to a family of calcium-dependent intracellular cysteine proteases. Both calpains are heterodimers consisting of a large catalytic subunit and a small regulatory subunit encoded by the gene Capn4. Ablation of the calpain small subunit eliminates calpain activity and leads to embryonic lethality. We previously created osteoblastspecific Capn4 knockout mice to investigate a physiological role for the calpain small subunit in cells of the osteoblast lineage. Deletion of Capn4 reduced trabecular and cortical bone, mainly due to impaired proliferation and differentiation of cells of the osteoblast lineage. To further investigate an underlining mechanism by which osteoblastspecific Capn4 knockout mice develop an osteoporotic bone phenotype, we established osteoblastic cell lines stably expressing either control or Capn4 RNA interference for this study. Capn4 knockdown cells showed reduced cell proliferation, accumulation of total and phosphorylated cyclin-dependent kinase inhibitor 1B (p27 Kip1 ) on serine 10, and reduced phosphorylation of retinoblastoma protein on threonine 821. Moreover, ablation of Capn4 increased 27 Kip1 mRNA levels, likely due to stabilized binding of Akt to protein phosphatase 2A, which presumably results in reduced phosphorylation of Akt on S473 and forkhead Box O (FoxO) 3A on T32. Collectively, calpain regulates cell proliferative function by modulating both transcription and degradation of p27 Kip1 in osteoblasts. In conclusion, calpain is a critical modulator for regulation of p27 Kip1 in cells of the osteoblast lineage.
osteoblast-specific Capn4 knockout mice. Deletion of Capn4 resulted in reduced trabecular and cortical bone, mainly due to reduced proliferation and differentiation of cells of the osteoblast lineage [10] . However, we failed to provide the underlying molecular mechanism by which deletion of the calpain small subunit modulates osteoblast function. In our more recent study using chondrocytespecific Capn4 knockout mice, we found that deletion of Capn4 reduces cell proliferation, at least in part, through accumulation of p27
Kip1 protein in cells of the chondrocyte lineage [11] . Therefore, to further test our hypothesis that calpain also critically modulates p27
Kip1 in cells of the osteoblast lineage, we established osteoblast cell lines stably expressing either control or Capn4 RNA interference (RNAi) and examined whether and how knockdown of Capn4 modulates p27 Kip1 protein levels in cells of the osteoblast lineage in vitro in this study.
Materials and Methods

Cell Lines and Antibodies
Mouse osteoblastic cells, MC3T3 subclone4 (MC4; ATCC, Manassas, VA), stably expressing either control or Capn4 microRNAs, were established as we described previously [11] . Control and Capn4 microRNAs were commercially available from Invitrogen (Carlsbad, CA). Four monoclonal cell lines were established, and knockdown of the calpain small subunit was assessed by calpain activity assay, as we described previously [10] . MC4 stable cell lines were cultured in a-minimal essential medium (Invitrogen) supplemented with 10% fetal bovine serum (HyClone, Logan, UT) and 1% penicillin-streptomycin (Invitrogen). Mouse p27
Kip1 siRNAs (Invitrogen) were also used to knockdown p27
Kip1 protein, as we described previously [11] . Antibodies against protein phosphatase 2A (PP2A), total (t)-Akt, t-FoxO3A, phosphorylated (p)-Akt (S473), p-FoxO3A (T32) (Cell Signaling Technology, Danvers, MA), cyclin D, cyclin E, p27 Kip1 , cyclin-dependent kinases 2 (cdk2) and 4 (cdk4) (Santa Cruz Biotechnology, Santa Cruz, CA), p-retinoblastoma protein (Rb, T821; Invitrogen), and p-p27 Kip1 (S10; Abcam, Cambridge, MA) were purchased.
Osteoblast Apoptosis Assay In Vitro
To assess apoptosis of established cell lines, cells were stained with annexin V-phycoerythrin and seven-amino actinomycin D using the Guava PCA Nexin kit and analyzed by a Guava Personal Cytometer (Guava Technology, Hayward, CA), as described previously [10, 11] .
Flow Cytometry
Cell cycle analysis was performed using flow-cytometric analysis, as we described previously [10] . MC4 cells stably expressing control or Capn4 microRNA were serumstarved (1% FBS) for 2 days and then stimulated by serum replacement (10% FBS) for 10 hours. Cells were labeled with 10 lM bromodeoxyuridine (BrdU) for the last 1 hour, harvested, and stained with anti-BrdU fluorescein isothiocyanate antibody for BrdU and propidium iodine for DNA as recommended by the manufacturer (Becton Dickinson, San Jose, CA). A total of 10,000 events were analyzed for each sample. The percentage of cells in G 1 , S, and G 2 /M phases of the cell cycle was determined by use of a Becton Dickinson LSRII analyzer, followed by analysis using FlowJo (Tree Star, Ashland, OR) software.
Calpain Activity Assay
Calpain activity assay was performed as we described previously [10] . In brief, cell lysates (10 lg/sample) were incubated with 200 lM calpain substrate, N-succinyl-LeuLeu-Val-Tyr-7-amino-4-methylcoumarin (Bachem, Torrance, CA) in a buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 1 mM EDTA, 1 mM dithiothreitol, and 3 mM Ca 2? at 37°C for 20 minutes. Fluorescence was measured at 460 nm with excitation at 355 nm using a Vector3 plate reader, and data were analyzed using Wallac software (Perkin-Elmer Life and Analytical Science, Waltham, MA). 7-Amino-4-methylcoumarine (Bachem) was used as a standard.
Real-Time Quantitative RT-PCR
Real-time quantitative RT-PCR was performed as described previously [10] . Samples were run in duplicate, and the results were normalized to GAPDH expression. Primer sequences for GAPDH, Cyclin D1, Cyclin E1, and p27 
Western Blot and Immunoprecipitation Analyses
Western blot analysis was performed as described previously [10] with antibodies against the following proteins: cyclin D, cyclin E, cdk2, cdk4, p27 Kip1 , p-Rb (T821), p-p27 Kip1 (S10), t-Akt, p-Akt (S473), t-FoxO3A, and p-FoxO3A (T32). In some experiments, blots were incubated in Restore Western blot stripping buffer (Thermo Scientific, Rockford, IL) and reprobed with other primary antibodies. The intensity of the selected protein bands was semiquantified using FluorChem SP (Alpha Innotech, San Leandro, CA). The relative density of p-Akt (S473)/t-Akt and p-FoxO3A(T32)/t-FoxO3A at time 0 was set as 1 in control and Capn4-kdn cells, respectively. A rate constant for dephosphorylation of p-Akt (S473) and p-FoxO3A (T32) was calculated using one phase exponential decay curve fit program of Prism 4 Software (GraphPad Software, La Jolla, CA).
For immunoprecipitation analysis, MC4 cells stably expressing either control or Capn4 RNAi were harvested, and cell lysates were precleared with 0.5 lg/mL normal mouse IgG agarose (Santa Cruz Biotechnology) for 2 hours at 4°C with agitation. One milligram of protein of the supernatant was incubated with 2 lg of primary antibodies to Akt for 1 hour at 4°C and then with 40 lL of protein A/G agarose (Santa Cruz Biotechnology) overnight at 4°C. Samples were washed, dissolved in sample buffer, and resolved on a 10% SDS gel, followed by Western blot analysis using anti-PP2A antibody. Some samples were also used for phosphatase activity assay.
PP2A Activity
PP2A activity was measured using the Immunoprecipitation Phosphatase Assay Kit (Millipore, Bedford, MA) with modification using 2 nM okadaic acid, a PP2A inhibitor [12] .
Statistics
Data were calculated from three or more independent experiments and expressed as the mean ± SE. Statistical analysis was performed using unpaired Student's t-test or analysis of variance. P \ 0.05 was accepted as significant.
Results
Osteoblast Cell Lines Stably Expressing Capn4 RNAi Were Established
To test a role of Capn4 in cell proliferation of the osteoblast lineage, we created MC4 cell lines stably expressing either control or Capn4 microRNA. The average calpain activities of established cell lines, MC4-Capn4 microRNA 1 and 2, were 50% and 35% vs. MC4-control microRNA (control) line 107 ± 2% (n = 4), respectively. We used the MC4-Capn4 microRNA 2 (Capn4 knockdown [kdn]) cell line, whose calpain activity was reduced to approximately 35% of that of control cells, in most of our experiments.
Deletion of Capn4 in Cells of the Osteoblast Lineage Increases p27
Kip1 Protein Levels by Reducing CalpainMediated Degradation of p27 Kip1 Stable deletion of Capn4 in osteoblasts showed impaired cell growth, assessed by cell number (Fig. 1a) . Proliferation of control and Capn4 kdn cells was assessed by BrdU incorporation followed by flow cytometry; the number of BrdU-positive cells was reduced by approximately 30% in Capn4 kdn cells compared with control cells (cells in S phase control 24 ± 3% vs. Capn4 kdn 16 ± 2%). No difference was observed in apoptosis between control and Capn4 kdn osteoblastic cells (apoptotic cells control 8.8 ± 0.3% vs. Capn4 kdn 7.1 ± 1.1%). Collectively, knockdown of Capn4 impairs cell proliferation of the osteoblast lineage, as we reported previously [11] .
To identify a mechanism by which knockdown of Capn4 reduces cell proliferation of the osteoblast lineage, we next examined mRNA expression of the cell cycle proteins cyclin D1 and cyclin E1. Expression of cyclin D1 mRNA was significantly reduced in Capn4 kdn MC4 osteoblastic cells (Fig. 1b) ; this result was consistent with our reports that mRNA expression of c-fos, a downstream target of PTH and a positive regulator of cyclin D transcription, is impaired by ablation of Capn4 in cells of the osteoblast [10] and chondrocyte [11] lineages. Levels of various cell cycle proteins were next examined. Despite reduced cyclin D1 mRNA levels (Fig. 1b) , increased protein levels of p27 Kip1 ( Fig. 1c-e ) and cyclin D (Fig. 1d, e) were detected by Western blot analysis. Notably, p27
Kip1 and cyclin D are calpain substrates [13, 14] . We also observed reduced phosphorylation of Rb on T821 in Capn4 kdn cells compared with control cells (Fig. 1d, e ). There were no significant differences in protein levels of cdk4 (Fig. 1d, e) , cyclin E, cdk 2, and cyclin-dependent kinase inhibitor 1A (p21 Cip1 ) (data not shown) between control and Capn4 kdn osteoblasts. Thus, these results suggest that, despite increased cyclin D protein levels, increased p27
Kip1 effectively blocks a cyclin D-cdk4 complex and reduces phosphorylation of Rb, resulting in impaired cell cycle transition at G 1 /S, as we described previously in cells of the chondrocyte lineage [11] .
Moreover, phosphorylation of p27 Kip1 on S10 was previously shown by others and us to be associated with calpain-mediated degradation of p27 Kip1 ; ablation of Capn4 impairs phosphorylation of p27 Kip1 on S10 [11] and removal of p-S10 p27
Kip1 through a calpain-mediated degradation pathway [15] . Deletion of Capn4 in osteoblastic cells also showed approximately twofold increased levels of p-S10 p27
Kip1 protein (Fig. 1d, e) , suggesting impaired calpain-mediated degradation of p-S10 p27 Kip1 protein in osteoblasts. Next, we tested whether additional knockdown of p27
Kip1 rescues an impaired cell growth phenotype of cells of the osteoblast lineage. We observed significantly normalized cell number in Capn4 and p27 Kip1 double knockdown cells compared with in Capn4 kdn cells (Fig. 1f) . These results were consistent with our previous report on cells of the chondrocyte lineage [11] . Collectively, knockdown of Capn4 in cells of the osteoblast lineage increases p27
Kip1 protein levels, at least partially, by reducing calpain-mediated removal of p27 Kip1 .
Moreover, reduction of p27 Kip1 protein levels can, at least partially, rescue an impaired cell proliferative function of Capn4 kdn osteoblasts.
Kip1 Protein Levels by Increasing Transcription of p27 Kip1 Bertoli et al. [16] showed that p27
Kip1 protein levels are regulated by calpain-mediated modification of Akt/FoxO3A , at least partially, rescued a reduced cell growth phenotype of Capn4 kdn osteoblasts. At some time points, error bars were within symbols. *P \ 0.05, **P \ 0.01, ***P \ 0.005
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phosphorylation. Ablation of Capn4 reduces phosphorylation of Akt and FoxO3A, and hypophosphorylated FoxO3A translocates from cytoplasm to nucleus, where it presumably increases p27 Kip1 transcription through the direct binding of FoxO3A to the promoter of p27
Kip1 and, consequently, p27
Kip1 protein levels in embryonic fibroblasts. Therefore, we next examined whether knockdown of Capn4 alters p27
Kip1 mRNA levels and modifies phosphorylation of Akt and FoxO3A in cells of the osteoblast lineage. Our data showed that knockdown of Capn4 increases p27
Kip1 mRNA expression (Fig. 2a) and more rapidly reduces phosphorylation of Akt and FoxO3A than controls upon serum starvation (Fig. 2b) in proliferating osteoblasts prior to reaching confluence. We also semiquantified the intensity of the protein bands corresponding to p-Akt (S473) and p-FoxO3A (T32), which was then normalized by t-Akt and t-FoxO3A protein levels, respectively, at various time points (Fig. 2c) . The average rate constant for the dephosphorylation of p-Akt (S473) was 0.092 ± 0.018 in control cells vs. 0.171 ± 0.007 in Capn4 kdn cells and that for p-FoxO3A (T32) was 0.044 ± 0.009 in control cells vs. 0.121 ± 0.008 in Capn4 kdn cells. Thus, these results suggest that p-Akt and p-FoxO3A were likely dephosphorylated upon serum starvation approximately two and three times faster, respectively, in Capn4 kdn osteoblasts than controls. Collectively, p27
Kip1 protein levels are also regulated by calpain-mediated modification of Akt/FoxO3A signaling and a consequent increase of p27
Kip1 mRNA levels in cells of the osteoblast lineage. We next examined how deletion of Capn4 modifies phosphorylation of Akt. PP2A is a heterotrimer consisting of a scaffolding subunit, a variable regulatory subunit, and a catalytic subunit [17] . PP2A regulatory subunits B56 a and c are calpain substrates, and ablation of Capn4 increases the stability of PP2A, which thereby increases dephosphorylation of Akt in embryonic fibroblasts [16] . Our coimmunoprecipitation assay showed an increased intensity of PP2A protein band (Fig. 3a) and significantly increased PP2A activity (Fig. 3b) of the protein complex precipitated with anti-Akt antibody. Collectively, these results suggest that calpain modifies p27 Kip1 mRNA expression, at least in part, by modifying phosphorylation of Akt/FoxO3A in cells of the osteoblast lineage.
Discussion
Calpains are cysteine proteases, which have numerous diverse substrates and regulate various cellular functions [2] . We previously showed that osteoblast-specific Capn4 knockout mice exhibited significantly reduced trabecular and cortical bone at least partially due to reduced cell proliferation of the osteoblast lineage in vivo [10] . However, a limitation of our report was that we failed to identify a specific molecular target of calpain responsible for their bone phenotype. p27 Kip1 has been shown to be one of those critical target molecules of calpain, and calpain activity uniquely modulates levels of p27 Kip1 in vitro [11, 13, 15, 16, 18] . Consistent with our previous report in cells of the chondrocyte lineage [11] , we here showed that ablation of Capn4 reduces cell growth by decreased cell proliferation of the osteoblast lineage. Knockdown of Capn4 increases p27 Kip1 protein levels by reducing removal of p-S10-p27
Kip1 , a target of calpain-mediated degradation of p27 Kip1 , resulting in reduced phosphorylation of Rb. Additional ablation of p27
Kip1 protein, at least partially, rescues the impaired cell growth phenotype of Capn4 kdn osteoblastic cells. It was also shown previously that regulatory subunits of PP2A are calpain substrates; therefore, knockdown of calpain stabilizes PP2A protein in a protein complex assembled with Akt, which thereby promotes dephosphorylation of Akt and FoxO3A in embryonic fibroblasts [16] . The promoter region of p27
Kip1 contains binding sequences for FoxO3A [16] . Therefore, we next examined whether calpain regulates p27
Kip1 protein levels by increasing p27 Kip1 mRNA levels in cells of the osteoblast lineage. Knockdown of calpain increases the intensity and activity of PP2A in a PP2A-Akt protein complex, resulting in more rapid dephosphorylation of Akt and then FoxO3A in osteoblasts upon serum starvation. Collectively, calpain is also a critical modulator for p27
Kip1 in cells of the osteoblast lineage. Figure 4 shows a hypothetical scheme of calpain-mediated regulation of p27
Kip1 in cells of the osteoblast lineage. Knockdown of calpain increases stability of PP2A protein and activity assembled with Akt, resulting in reducing phosphorylation of Akt and then FoxO3A. Underphosphorylated FoxO3A translocates to nucleus and increases p27
Kip1 mRNA levels through direct binding to the p27
Kip1
promoter and increases p27 Kip1 protein levels. On the other hand, knockdown of calpain decreases calpain-mediated degradation of p27 Kip1 . Increased p27 Kip1 inactivates mainly cyclin D-cdk4, resulting in reduced phosphorylation of Rb and impaired cell cycle transition at G 1 /S.
The mechanisms by which intermittent administration of PTH shows an anabolic effect on bone have been intensively studied. Investigators have reached various conclusions depending on cell lines, dose and frequency of PTH administration, cell density, and culture conditions in in vitro studies [19] [20] [21] [22] [23] [24] [25] . However, a line of evidence has suggested that upregulation of p27
Kip1 and p21 Cip1 proteins [26, 27] through PTH-mediated increase of protein kinase A (PKA) signaling is positively associated with an anabolic action of PTH in bone [26] . Because we have shown previously that ablation of calpain significantly decreases PTH-mediated PKA signaling [9, 10] , calpain may uniquely increase p27
Kip1 protein levels, at least partially, through a mechanism independent of a PTH-PKA signaling pathway. Further studies will be necessary to demonstrate how calpain-mediated modulation of p27
Kip1 in bone affects anabolic action of PTH in vivo; however, our results at least suggest that calpain inhibition can be a critical therapeutic target for osteoporosis because it could increase the efficiency of the anabolic action of PTH by uniquely increasing p27 Kip1 protein levels in cells of the osteoblast lineage.
In conclusion, our current report suggests that calpain regulates p27
Kip1 protein levels by modifying p27 Kip1 protein degradation and p27
Kip1 transcription via phosphorylation of Akt/FoxO3A in cells of the osteoblast lineage. The intensity of protein bands of Capn4 kdn cells (C4-kdn) was higher than that of control cells (Cont.). b Deletion of Capn4 increases the activity of PP2A assembled with Akt in osteoblasts. Whole-cell lysate (1 mg) was immunoprecipitated with anti-Akt antibody. The intensity of the protein band assembled with Akt was assessed by Western blot analysis (a) and its activity of PP2A was determined using the Immunoprecipitation Phosphatase Assay (b). *P \ 0.05 Fig. 4 A hypothetical scheme of calpain-mediated regulation of p27
Kip1 protein in cells of the osteoblast lineage. Calpain modulates p27
Kip1 protein levels through increasing its transcription and reducing degradation in cells of the osteoblast lineage. Knockdown of calpain increases PP2A protein stability and activity assembled with Akt, resulting in reducing phosphorylation of Akt and then FoxO3A. Underphosphorylated FoxO3A translocates to the nucleus and increases p27
Kip1 mRNA levels through direct binding to the p27 Kip1 promoter and increases p27 Kip1 protein levels (left). On the other hand, knockdown of calpain also decreases calpain-mediated degradation of p27 Kip1 (right). Increased p27 Kip1 inactivates mainly cyclin D-cdk4, resulting in reduced phosphorylation of Rb and impaired cell cycle transition at G 1 /S in osteoblasts A. Kashiwagi 
